Below are some FAQs, please see if these answer your enquiry. If not please submit a question via the yellow button at the bottom of the page.
Yes, UKONS advertise job adverts via Breaking News, as mailshots to UKONS members, and on the UKONS website.
Yes, UKONS has a fixed fee for advertising one job to its members via Breaking News, mailshots and on the UKONS website for two consecutive weeks. The current advertising fee, which is subject to 20% VAT, can be found HERE
Yes, please obtain the format required for wording job adverts by contacting email@example.com. Note additional information about the post can be included by submitting a file in pdf format or a URL address, which UKONS will link to the advert using an html link.
The payment term is 30 days from the date of the invoice.
Please contact firstname.lastname@example.org who will forward your request to the UKONS Treasurer.
We advertise training days on the UKONS Acute Oncology MIG page and in our breaking news letter.
There is also a set of training slides on the Acute Oncology MIG page.
Please contact Philippa Jones via email@example.com
You can order the 24 Hour Triage tool manuals, log sheets, pocket tools and/or posters from Telford Reprographics. Please email Alex at firstname.lastname@example.org and ask for a price list and ordering instructions. UKONS is not involved with ordering or printing of the tool.
...work in progress..
Please complete the UKONS Request to Review a Project Form and return to Research MIG via email@example.com You will be advised if UKONS are able to support your request on receipt of the completed form.
Please complete the UKONS Request to Review a Project Form and return to Research MIG via firstname.lastname@example.org
You will be advised if UKONS are able to support your request on receipt of the completed form
Please contact the Research MIG via email@example.com to find out about permissions to use UKONS copyrighted documents.
Please view information in the UKONS Research MIG Recommended Resources section of the website.
UKONS will support, where possible, regional or national events that increase the knowledge, skills and expertise of cancer nurses in the UK. To make requests about support for specific educational events, please contact firstname.lastname@example.org
Please submit your request to email@example.com and the UKONS Board will be happy to respond.
Please view information in the UKONS News and Events section of the website.
To order your physical copy HERE.
The UKONS SACT passport answer guide is now accessible electronically. To request access please complete the ‘UKONS Declaration for access to the electronic SACT answer guide’ form found on the SACT MIG webpage.
A request for a UKONS SACT passport answer guide can be made by contacting firstname.lastname@example.org. Please state your name, role and area of work and provide a forwarding address.
UKONS position statement:
In 2016 at their annual conference UKONS were requested by our members to provide some guidance on the effectiveness of closed-system drug transfer devices (CSTD) in addition to safe handling of hazardous drugs versus safe handling alone for reducing healthcare staff exposure to infusional hazardous drugs.
In response to this request UKONS commissioned a Cochrane systematic review to provide us with independent high quality, robust research to provide sufficient and unambiguous information on the potential benefits and costs of CSTD to inform a position statement which we are delighted to announce has now been published.
To read the full position statement, please click HERE.
National Chemotherapy Board (NCB) GOOD PRACTICE GUIDELINE: Promoting Early Identification of Systemic Anti-Cancer Therapies Side Effects: – Two Approaches.
This guidance has been produced by the National Chemotherapy Board in response to concerns that patients often delay reporting serious Systemic Anti-Cancer Therapy (SACT) side effects to dedicated help lines. Two complementary approaches to improve side effect reporting are suggested:
1. Empowerment focuses on equipping patients to take responsibility for identifying and reporting important side effects and may be mediated via technology.
2. Proactive monitoring includes clinician interventions (e.g. telephone support or home visits).
3. The NCB Good Practice Guidelines are available HERE